News Focus
News Focus
icon url

corporalagarn

04/30/26 8:43 AM

#6080 RE: dewophile #6079

These cash runways assume ENTA partners the RSV phase 3, correct. Seven months after phase 2 results and it hasn’t happened. Going it alone would shorten it by some number of quarters. They could shelve it I guess, but I don’t see that happening.
icon url

wags23

04/30/26 9:40 AM

#6081 RE: dewophile #6079

2037 patents expire
icon url

DewDiligence

04/30/26 11:02 AM

#6083 RE: dewophile #6079

The US patent on Glecaprevir’s crystal formulations (9,321,807) runs until 12/5/2035. As far as I know, this is the longest-running patent relevant to Mavyret sales in the US. Patents that ABBV licensed from ENTA in some other countries may expire later.